Vaxcyte, Inc. · NASDAQ:PCVX

Guggenhime Andrew sold 10,000 Vaxcyte, Inc. shares (Form 4)

Traded Aug 3, 2026 · Filed Aug 5, 2026

On Aug 3, 2026, Guggenhime Andrew (PRESIDENT AND CFO) sold 10,000 Vaxcyte, Inc. shares at an average US$53.89 for US$539K under a trading plan, leaving 105,176 shares. Filed Aug 5, 2026 (Form 4).

Sold
10,000 shares
Price
US$53.89 average (US$53.76 to US$54.18)
Value
US$539K
Holding after
105,176 shares
Trading plan
Yes (Made under a plan set in advance)
Role
PRESIDENT AND CFO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 3, 2026Common StockOption exercise10,000US$5.35115,176Direct
Aug 3, 2026Common StockSale6,956US$53.76108,220Direct
Aug 3, 2026Common StockSale3,044US$54.18105,176Direct

Source

View original at SEC

Related